Searched for
API PRODUCTION
Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
- Creator platform Influish raises pre-seed round at Rs 25 crore valuationCreator platform Influish has secured pre-seed funding at a Rs 25 crore valuation, backed by angel investors. The platform connects creator...
- Sarvam: When US slams the door, India begins to find its own openingSarvam AI’s rise to a $1.5 bn valuation after raising $234 mn marks a major milestone for India’s push toward AI sovereignty. The funding c...
- Techie called ‘money-minded’ by CEO for asking salary hike after cutting down AI costs by 95%. 'You broke the manager's heart'A Reddit post by an AI engineering intern has gone viral after he claimed he was fired from a small startup shortly after requesting a sala...
- Hero FinCorp teams up with Salesforce to drive loan processing with AgentforceSalesforce and Hero FinCorp partnered to speed up loan processing. Hero FinCorp deployed Salesforce's Agentforce and other tools. This has ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- Keshav Reddy's Equal AI raises $30 million in round led by Prosus, Tomales Bay CapitalThe round also saw participation from Think Investments, Valiant Fund, PhonePe founder Sameer Nigam, and Zubin Bharti Mittal, among others....
- Liqvd Asia bets on AI, acquisitions to fuel next phase of growth ahead of SME IPOCreative-led digital agency Liqvd Asia is leveraging artificial intelligence and acquisitions for growth, aiming to provide faster, persona...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- Anthropic unveils Claude Fable 5, making a shift toward autonomous AI agentsAnthropic has launched Claude Fable 5 and Claude Mythos 5, introducing a new class of AI models designed for long-horizon, autonomous tasks...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- India makes a quantum leap: India's first quantum-safe algorithm gets certified: Fortytwo Labs earns C-SAFE recognition from DSCIIndia has achieved a significant milestone with the independent evaluation and national recognition of its first domestically built quantum...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- Claude AI down: Anthropic AI chatbot faces partial outage as users report access issuesClaude AI Down Today: Claude AI users reported widespread access issues after Anthropic confirmed elevated error rates affecting multiple s...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
Load More
